Product Information

ACITRETIN 17.5 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $4.4994 per EA under NDC 62332074230. Its NADAC has been published 102 times since Dec 4, 2024.

FDA first approved this application on Aug 5, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACITRETIN 17.5 MG CAPSULE

Acitretin
$4.4994per EA

Strength

17.5 mg/1

NDC

62332074230

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ACITRETIN

Approval Type

Generic (ANDA)

FDA Application

ANDA217774

FDA Approved

8/5/2024

TE Code

AB

On Market Since

8/8/2024

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ACITRETIN 17.5 MG CAPSULE has been published 102 times since Dec 4, 2024, and over the history we have for it it has declined 65.9%. The table below summarizes its recorded NADAC range and movement.

Current price$4.4994 per EA
All-time high$13.2128 (Dec 11, 2024)
All-time low$4.4994 (Oct 21, 2026)
52-week high$7.9486
52-week low$4.4994
Median price$6.3673
Average price$7.1845
Largest weekly change+55.6% (Jan 21, 2026)
Weeks tracked102
Tracking sinceDec 4, 2024

Price History

1W

0.0%

1M

-0.4%

3M

-1.8%

6M

-29.3%

1Y

-11.9%

3Y

N/A

5Y

N/A

All

-65.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACITRETIN 17.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ACITRETIN 17.5 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $4.4994 per EA (NDC 62332074230), effective Nov 11, 2026.

How has the price of ACITRETIN 17.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ACITRETIN 17.5 MG CAPSULE has declined 65.9%. It has been tracked across 102 weekly CMS publications since Dec 4, 2024.

What are the highest and lowest recorded NADAC prices for ACITRETIN 17.5 MG CAPSULE?

Since Dec 4, 2024, the NADAC for ACITRETIN 17.5 MG CAPSULE has ranged from a low of $4.4994 (Oct 21, 2026) to a high of $13.2128 (Dec 11, 2024), with a median of $6.3673 per EA.

Are there cheaper alternatives to ACITRETIN 17.5 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACITRETIN 17.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures ACITRETIN 17.5 MG CAPSULE?

ACITRETIN 17.5 MG CAPSULE (NDC 62332074230) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.